Why the study?
Does Bao-Xin-Tang reduce myocardial infarct size and inflammatory markers in a rat model of acute myocardial infarction?
Does Bao-Xin-Tang reduce myocardial infarct size and inflammatory markers in a rat model of acute myocardial infarction?
Bao-Xin-Tang demonstrates cardioprotective effects in a rat model of acute myocardial infarction by reducing infarct size and modulating inflammatory and oxidative stress markers.
BACKGROUND: Bao-Xin-Tang (BXT) is a traditional Chinese medicinal formula used for the treatment of coronary heart disease and known to have favorable therapeutic benefits. The current study was designed to determine whether BXT has a cardioprotective role for acute myocardial infarction. The underlying mechanisms were also explored. MATERIALS AND METHODS: The Sprague-Dawley rat model of acute myocardial infarction was established by occluding the left anterior descending branch of the coronary artery. After a 3-h ischemic period, we determined the myocardial infarction size, inflammatory components, and antioxidant activities. RESULTS: The data showed that BXT could reduce the infarction size and lower the levels of C-reactive protein, interleukin-6, and myeloperoxidase, and increase the activities of superoxide dismutase and the anti-inflammatory cytokine, interleukin-10. These results indicate that administration of BXT, following acute myocardial infarction, could reduce infarct size. CONCLUSION: The effects of BXT may be related to its anti-inflammatory and anti-oxidative properties.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: